08/27/2025
We’re celebrating our LaVilla site team for their amazing work on the BaxHTN trial — a study testing baxdrostat, a once-daily pill designed to help people with tough-to-control high blood pressure.
💡 What the study found (after 12 weeks):
✅ Big drop in systolic blood pressure vs placebo
✅ More patients got below 130 mmHg (a key goal for hypertension)
✅ Improvements in diastolic blood pressure
✅ Well tolerated, with a good safety profile
This is a huge step forward for patients living with hypertension — and we’re so proud of our team for helping make it happen. 💙
👏 Way to go, LaVilla — your hard work is changing lives!
